Exploring how PIM kinases control tumor survival and resistance in diffuse large B-cell lymphoma (DLBCL) through epigenetic and transcriptional mechanisms.
Discover how OTUD7B, a deubiquitinase enzyme, serves as a prognostic biomarker in diffuse large B-cell lymphoma (DLBCL) and its potential therapeutic implications.